After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, CRNX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Crinetics Pharmaceuticals Inc is $5.74B. A total of 0.76 million shares were traded on the day, compared to an average of 1.40M shares.
In the most recent transaction, Kalofonos Isabel sold 2,500 shares of CRNX for 55.00 per share on Jan 05 ’26. After the transaction, the Chief Commercial Officer now owns 834 company shares. In a previous transaction on Jan 05 ’26, ISABEL KALOFONOS bought 2,500 shares at 46.73 per share.
Among the insiders who bought shares, DANA PIZZUTI acquired of 5,000 shares on Jan 02 ’26 at a per-share price of $46.55. In another insider transaction, Pizzuti Dana sold 5,000 shares at $45.02 per share on Dec 01 ’25. Company shares held by the Chief Med and Dev Officer now total 66,837.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CRNX has a high of $57.99 and a low of $24.10.
As of this writing, CRNX has an earnings estimate of -$1.38 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of -$1.25 per share and a lower estimate of -$1.52. The company reported an EPS of -$0.88 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CRNX’s latest balance sheet shows that the firm has $333.71M in Cash & Short Term Investments as of fiscal 2021. There were $3.07M in debt and $15.99M in liabilities at the time. Its Book Value Per Share was $11.34, while its Total Shareholder’s Equity was $331.94M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
